SIA Novartis BalticsActive
Key figures
Ratios
2025Balance sheet structure
Dividends
from the reportDividends paid 1 400 000 € (18% of equity at the end of the previous year).
Summary of financial statements2017–2025
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||||
| Total current assets | 2 999 454 | 23 986 350 | 29 296 848 | 26 101 826 | 28 824 850 | 42 232 300 | 36 432 307 | 40 327 431 | 43 392 117 |
| Total non-current assets | 0 | 125 981 | 112 493 | 442 956 | 328 306 | 286 683 | 239 713 | 957 754 | 503 086 |
| Total assets | 2 999 454 | 24 112 331 | 29 409 341 | 26 544 782 | 29 153 156 | 42 518 983 | 36 672 020 | 41 285 185 | 43 895 203 |
| Balance sheet — liabilities and equity | |||||||||
| Current liabilities | 0 | 19 542 691 | 21 652 390 | 15 923 370 | 14 889 499 | 26 300 415 | 31 737 393 | 33 437 747 | 32 497 522 |
| Non-current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | 0 | 19 542 691 | 21 652 390 | 15 923 370 | 14 889 499 | 26 300 415 | 31 737 393 | 33 437 747 | 32 497 522 |
| Share capital | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — |
| Profit for the year | -546 | 1 570 186 | 3 187 311 | 2 864 461 | 3 642 245 | 1 954 911 | -20 284 | 2 912 811 | 4 950 243 |
| Total equity | 2 999 454 | 4 569 640 | 7 756 951 | 10 621 412 | 14 263 657 | 16 218 568 | 4 934 627 | 7 847 438 | 11 397 681 |
| Income statement | |||||||||
| Sales revenue | 0 | 52 939 066 | 57 013 988 | 63 510 390 | 71 129 673 | 77 413 076 | 86 909 819 | 95 145 326 | 107 723 206 |
| Operating profit | -546 | 1 931 539 | 3 428 202 | 3 003 317 | 3 778 890 | 2 090 091 | 2 572 470 | 3 128 004 | 5 391 124 |
| Profit before income tax | -546 | 1 924 915 | 3 424 895 | 3 002 547 | 3 777 699 | 2 111 192 | 2 820 099 | 3 153 324 | 5 542 703 |
| Profit for the reporting year | -546 | 1 570 186 | 3 187 311 | 2 864 461 | 3 642 245 | 1 954 911 | -20 284 | 2 912 811 | 4 950 243 |
| Labour costs | — | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | — | — | — | — | — | — | — | — | — |
| Other indicators | |||||||||
| Employees | 0 | 98 | 107 | 108 | 119 | 117 | 98 | 98 | 96 |
| Calculated dividend | — | 0 | 0 | 0 | 0 | 0 | 11 263 657 | 0 | 1 400 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
Related companies
Summary: SIA Novartis Baltics
Overview
SIA Novartis Baltics (reg. no. 40203071239) is a limited liability company. The company was registered in 2017 and has been in the register for 9 years. Registered address: Rīga, Skanstes iela 25.
Financial results
Revenue in 2025 was 107 723 206 €, up 13,2% on the previous year (95 145 326 €). This is the company's highest revenue among the published years (2017–2025). Net profit for 2025 was 4 950 243 € (4,6% of revenue). The company was profitable in 7 of the 9 published years. In 2025 the company had 96 employees (98 a year earlier). Revenue per employee was 1 122 117 €. At the end of 2025, total assets were 43 895 203 € and equity 11 397 681 € (26,0% of assets).
Management and owners
The board has 3 members. The sole owner of the company is Novartis Pharma AG.
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.